Skip navigation

Canlyniadau chwilio am the

Yn dangos 361 i 375 o 2068 canlyniadau

Protected function - hearing aid dispensers

We regulate hearing aid dispensers on the basis of their professional title and also their protected function.

Digital skills and new technologies

We have emphasised the need to be able to keep up to date with digital skills and new technologies. This is one theme within the key changes to the updated standards of proficiency for all professions.

Fitness to practise annual report 2008

This report provides information about the HPC’s work in considering allegations about the fitness to practise of our registrants.

Registration Appeals Panel Members

Registration Appeals Panel Members consider and determine appeals regarding admittance to the register, renewal and removal from the register

Consultation on Standards for prescribing

We are consulting on proposed changes to the Standards for prescribing.

HCPC statement on guidance on health and character and suicidal ideation

Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.

HCPC response to the HEE consultation on framework 15

 View our response to the Health Education England consultation on framework 15.

Fitness to practise FAQs

Frequently asked questions about the HCPTS and fitness to practise hearings

Other organisations

This page lists the other organisations that are responsible for regulating, and investigating concerns about, health and care professionals in the UK.

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)